AstraZeneca admits!

AstraZeneca admits for first time its Covid vaccine CAN cause rare side effect

AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect.

The exceedingly rare reaction is at the heart of a multi million-pound class action by dozens of families who allege they, or their loved ones, were maimed or killed by the pharmaceutical titan's 'defective' vaccine. 

Cambridge-based AstraZeneca, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.

TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot. 

AstraZeneca's admission could lead to pay-outs on a case-by-case basis.  

Although accepted as a potential side effect for two years, it marks the first time the company has admitted in court that its jab can cause the condition.

AstraZeneca said in a statement: 'Our sympathy goes out to anyone who has lost loved ones or reported health problems. 

'Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.

'From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.'